« Previous
Next »
Titles
- Data elements for research on the role of social determinants of health in Coronavirus disease 2019: infection and outcomes in the U.S1
- Defense health agency: oversight needed to better ensure that children are screened, tested, and treated for lead exposure : report to congressional committees1
- Defense health care: Actions needed to improve billing and collection of debt for civilian emergency care : report to congressional committees1
- Defense health care: DOD expects new IT system capabilities to improve other health insurance processing : report to congressional committees1
- Defense health care: Prevalence of and efforts to screen and treat mental health conditions in prenatal and postpartum TRICARE beneficiaries : report to congressional committees1
- Delays in confirmatory trials for drug applications granted FDA’s accelerated approval raise concerns1
- Demographic characteristics of adults receiving COVID-19 booster vaccinations1
- Denture base resins: performance criteria for safety and performance based pathway : guidance for industry and Food and Drug Administration Staff1
- Doula care and maternal health: an evidence review1
- Drug product tracing: the effect of section 585 of the FD&C Act : questions and answers1
- Drug products, including biological products, that contain nanomaterials1
- Drug safety: FDA should take additional steps to improve its foreign inspection program : report to congressional requesters1
- During the initial COVID-19 response, HHS personnel who interacted with potentially infected passengers had limited protections1